Internal Medicine · Bowling Green, KY
NPI
1639173495
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
990 Wilkinson Trce
Bowling Green, KY, 42103
Phone (270) 782-4746
Groups this clinician bills Medicare through
Medicare paid, 2024
$296K
14,117 services
Medicare patients, 2024
410
Average age 74
Drug cost, 2024
$2.1M
15,947 prescriptions
Company payments, 2025
$2,743
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hope Havener was code J0897 (injection, denosumab, 1 mg), 2,760 times for 29 patients. In total Hope Havener billed 14,117 services in 197 codes, and Medicare paid $296K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,760 | 29 | $20.38 | $56K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,775 | 16 | $0.10 | $184 |
| 99214 Office E&M - Established | Office | 736 | 302 | $81.87 | $60K |
| 80053 Clinical Chemistry | Office | 566 | 340 | $10.34 | $5,851 |
| 80061 Clinical Chemistry | Office | 466 | 312 | $13.09 | $6,098 |
| 84443 Clinical Chemistry | Office | 445 | 311 | $16.44 | $7,314 |
| 85025 Blood Count | Office | 439 | 301 | $7.61 | $3,341 |
| 84439 Clinical Chemistry | Office | 389 | 277 | $8.81 | $3,427 |
| 84481 Clinical Chemistry | Office | 368 | 267 | $16.52 | $6,080 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 352 | 39 | $0.75 | $262 |
| 83721 Clinical Chemistry | Office | 331 | 239 | $10.25 | $3,392 |
| 83036 Blood Count | Office | 230 | 139 | $9.50 | $2,185 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 211 | 211 | $122.57 | $26K |
| 82570 Clinical Chemistry | Office | 150 | 94 | $5.08 | $762 |
| 82043 Clinical Chemistry | Office | 149 | 93 | $5.66 | $843 |
By year: 2022 $241K for 9,990 services; 2023 $259K for 11,523 services; 2024 $296K for 14,117 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 566 | 340 | $10.34 | $5,851 |
| 80061 Clinical Chemistry | 466 | 312 | $13.09 | $6,098 |
| 84443 Clinical Chemistry | 445 | 311 | $16.44 | $7,314 |
| 85025 Blood Count | 439 | 301 | $7.61 | $3,341 |
| 84439 Clinical Chemistry | 389 | 277 | $8.81 | $3,427 |
| 84481 Clinical Chemistry | 368 | 267 | $16.52 | $6,080 |
| 83721 Clinical Chemistry | 331 | 239 | $10.25 | $3,392 |
| 83036 Blood Count | 230 | 139 | $9.50 | $2,185 |
| 82570 Clinical Chemistry | 150 | 94 | $5.08 | $762 |
| 82043 Clinical Chemistry | 149 | 93 | $5.66 | $843 |
Medicare prescription drug claims, 2024
In 2024, the drug Hope Havener prescribed most often to Medicare patients was Rosuvastatin Calcium, with 687 prescriptions and refills. In total Hope Havener wrote 15,947 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 687 | 1,845 | 198 | $8,224 |
| Levothyroxine Sodium Generic | 652 | 1,637 | 167 | $5,543 |
| Metoprolol Succinate Generic | 503 | 1,278 | 130 | $6,335 |
| Amlodipine Besylate Generic | 422 | 1,030 | 116 | $1,785 |
| Atorvastatin Calcium Generic | 347 | 949 | 107 | $2,215 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 335 | 335 | 62 | $7,097 |
| Montelukast Sodium Generic | 319 | 806 | 87 | $2,587 |
| Losartan Potassium Generic | 314 | 828 | 98 | $2,615 |
| Omeprazole Generic | 309 | 699 | 80 | $2,729 |
| Olmesartan Medoxomil Generic | 297 | 781 | 76 | $5,818 |
| Desloratadine Generic | 276 | 655 | 98 | $11K |
| Nebivolol Hcl Generic | 263 | 623 | 70 | $7,767 |
| Gabapentin Generic | 252 | 273 | 36 | $1,489 |
| Pravastatin Sodium Generic | 249 | 617 | 70 | $2,659 |
| Ondansetron Odt Ondansetron | 241 | 258 | 85 | $3,407 |
Brand drugs: 2,570 claims; generic drugs: 13,324 claims; opioid claims: 626.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hope Havener $2,743 ($2,743 in general payments such as food, travel and fees) from 24 companies. The largest payer was Novo Nordisk Inc with $400.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 24 | $400 |
| Pfizer Inc. PFE | 13 | $238 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 14 | $224 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $223 |
| Phathom Pharmaceuticals, Inc. PHAT | 15 | $207 |
| Amgen Inc. AMGN | 12 | $189 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $172 |
| Abbvie Inc. ABBV | 10 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $149 |
| Sumitomo Pharma America, Inc. 4506.T | 8 | $143 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.